Pros: the Present Classification of Mucinous Adenocarcinomas of the Lung

Overview

Journal Transl Lung Cancer Res

Date 2017 May 23

PMID 28529905

Citations 13

Authors

Sanja Dacic

Affiliations

Soon will be listed here.

Citing Articles

Concomitance of Pericardial Tamponade and Pulmonary Embolism in an Invasive Mucinous Lung Adenocarcinoma with Atypical Presentation: Diagnostic and Therapeutic Pitfalls-Case Report and Literature Review.

Bertici N, Tudoran C, Bertici R, Fira-Mladinescu O, Jianu D, Streian C Int J Mol Sci. 2024; 25(15).

PMID: 39125981 PMC: 11313361. DOI: 10.3390/ijms25158413.

Efficacy of Touch Imprint Cytology in Intraoperative Diagnosis of Invasive Mucinous Adenocarcinoma of the Lung: A Case Report and Literature Review.

Kato T, Higuchi Y, Oshima M, Endo F, Sato F, Sugihara S Clin Pract. 2024; 14(1):242-249.

PMID: 38391405 PMC: 10888414. DOI: 10.3390/clinpract14010019.

Morphologically intact airways in lung fibrosis have an abnormal proteome.

Herrera J, Dingle L, Monetero M, Venkateswaran R, Blaikley J, Granato F Respir Res. 2023; 24(1):99.

PMID: 37005656 PMC: 10066954. DOI: 10.1186/s12931-023-02400-x.

Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.

Cui D, Xie S, Liu Q BMC Pulm Med. 2023; 23(1):9.

PMID: 36624430 PMC: 9830770. DOI: 10.1186/s12890-023-02305-x.

Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.

Woo W, Yang Y, Cha Y, Moon D, Shim H, Cho A Thorac Cancer. 2022; 13(23):3310-3321.

PMID: 36345148 PMC: 9715870. DOI: 10.1111/1759-7714.14687.

References

Kadota K, Yeh Y, DAngelo S, Moreira A, Kuk D, Sima C . Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol. 2014; 38(8):1118-27. PMC: 4666292. DOI: 10.1097/PAS.0000000000000246. View

Travis W, Garg K, Franklin W, Wistuba I, Sabloff B, Noguchi M . Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005; 23(14):3279-87. DOI: 10.1200/JCO.2005.15.776. View

Yousem S, Nikiforova M, Nikiforov Y . The histopathology of BRAF-V600E-mutated lung adenocarcinoma. Am J Surg Pathol. 2008; 32(9):1317-21. DOI: 10.1097/PAS.0b013e31816597ca. View

Motoi N, Szoke J, Riely G, Seshan V, Kris M, Rusch V . Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol. 2008; 32(6):810-27. DOI: 10.1097/PAS.0b013e31815cb162. View

Rossi G, Murer B, Cavazza A, Losi L, Natali P, Marchioni A . Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Am J Surg Pathol. 2004; 28(4):442-52. DOI: 10.1097/00000478-200404000-00003. View

Nakaoku T, Tsuta K, Ichikawa H, Shiraishi K, Sakamoto H, Enari M . Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. Clin Cancer Res. 2014; 20(12):3087-93. PMC: 6329293. DOI: 10.1158/1078-0432.CCR-14-0107. View

Shim H, Kenudson M, Zheng Z, Liebers M, Cha Y, Hoang Ho Q . Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung. J Thorac Oncol. 2015; 10(8):1156-62. DOI: 10.1097/JTO.0000000000000579. View

Lau S, Desrochers M, Luthringer D . Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. Mod Pathol. 2002; 15(5):538-42. DOI: 10.1038/modpathol.3880560. View

Yatabe Y, Koga T, Mitsudomi T, Takahashi T . CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas. J Pathol. 2004; 203(2):645-52. DOI: 10.1002/path.1566. View

10.

Dhanasekaran S, Balbin O, Chen G, Nadal E, Kalyana-Sundaram S, Pan J . Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes. Nat Commun. 2014; 5:5893. PMC: 4274748. DOI: 10.1038/ncomms6893. View

11.

Finberg K, Sequist L, Joshi V, Muzikansky A, Miller J, Han M . Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. J Mol Diagn. 2007; 9(3):320-6. PMC: 1899415. DOI: 10.2353/jmoldx.2007.060182. View

12.

Inamura K, Satoh Y, Okumura S, Nakagawa K, Tsuchiya E, Fukayama M . Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol. 2005; 29(5):660-5. DOI: 10.1097/01.pas.0000160438.00652.8b. View

13.

Hwang D, Sholl L, Rojas-Rudilla V, Hall D, Shivdasani P, Garcia E . KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung. J Thorac Oncol. 2016; 11(4):496-503. DOI: 10.1016/j.jtho.2016.01.010. View

14.

Marchetti A, Buttitta F, Pellegrini S, Chella A, Bertacca G, Filardo A . Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J Pathol. 1996; 179(3):254-9. DOI: 10.1002/(SICI)1096-9896(199607)179:3<254::AID-PATH589>3.0.CO;2-J. View

15.

Zenali M, Weissferdt A, Solis L, Ali S, Tang X, Mehran R . An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung. Hum Pathol. 2015; 46(6):836-42. DOI: 10.1016/j.humpath.2014.10.032. View

16.

Travis W, Brambilla E, Noguchi M, Nicholson A, Geisinger K, Yatabe Y . International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011; 6(2):244-85. PMC: 4513953. DOI: 10.1097/JTO.0b013e318206a221. View

17.

Skoulidis F, Byers L, Diao L, Papadimitrakopoulou V, Tong P, Izzo J . Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov. 2015; 5(8):860-77. PMC: 4527963. DOI: 10.1158/2159-8290.CD-14-1236. View

18.

Fernandez-Cuesta L, Plenker D, Osada H, Sun R, Menon R, Leenders F . CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discov. 2014; 4(4):415-22. DOI: 10.1158/2159-8290.CD-13-0633. View

19.

Sumiyoshi S, Yoshizawa A, Sonobe M, Kobayashi M, Sato M, Fujimoto M . Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis. Lung Cancer. 2014; 84(3):281-8. DOI: 10.1016/j.lungcan.2014.03.013. View